236 related articles for article (PubMed ID: 23469196)
1. The different immunoregulatory functions on dendritic cells between mesenchymal stem cells derived from bone marrow of patients with low-risk or high-risk myelodysplastic syndromes.
Wang Z; Tang X; Xu W; Cao Z; Sun L; Li W; Li Q; Zou P; Zhao Z
PLoS One; 2013; 8(3):e57470. PubMed ID: 23469196
[TBL] [Abstract][Full Text] [Related]
2. The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes.
Zhao Z; Wang Z; Li Q; Li W; You Y; Zou P
PLoS One; 2012; 7(9):e45675. PubMed ID: 23029178
[TBL] [Abstract][Full Text] [Related]
3. The characteristics and immunoregulatory functions of regulatory dendritic cells induced by mesenchymal stem cells derived from bone marrow of patient with chronic myeloid leukaemia.
Zhao ZG; Xu W; Sun L; Li WM; Li QB; Zou P
Eur J Cancer; 2012 Aug; 48(12):1884-95. PubMed ID: 22129888
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function.
Reis M; Mavin E; Nicholson L; Green K; Dickinson AM; Wang XN
Front Immunol; 2018; 9():2538. PubMed ID: 30473695
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells.
Zhao ZG; Xu W; Sun L; You Y; Li F; Li QB; Zou P
Immunol Invest; 2012; 41(2):183-98. PubMed ID: 21936678
[TBL] [Abstract][Full Text] [Related]
6. Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes.
Zhao ZG; Xu W; Yu HP; Fang BL; Wu SH; Li F; Li WM; Li QB; Chen ZC; Zou P
Cancer Lett; 2012 Apr; 317(2):136-43. PubMed ID: 22240014
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function.
Sarhan D; Wang J; Sunil Arvindam U; Hallstrom C; Verneris MR; Grzywacz B; Warlick E; Blazar BR; Miller JS
JCI Insight; 2020 Mar; 5(5):. PubMed ID: 32045384
[TBL] [Abstract][Full Text] [Related]
8. [Immuno-suppressive effects on T cells mediated by mesenchymal stem cells from patients with myelodysplastic syndrome].
Liu LH; Chen H; Chen B; Sun Z; Ye LP; Shi B; Jin JG; Zhao CH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):299-304. PubMed ID: 18426653
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1 Transduced Mesenchymal Stem Cells Have Profound Modulatory Effects on DCs and T Cells.
Daneshmandi S; Karimi MH; Pourfathollah AA
Iran J Immunol; 2017 Mar; 14(1):13-23. PubMed ID: 28341815
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization.
Flores-Figueroa E; Arana-Trejo RM; Gutiérrez-Espíndola G; Pérez-Cabrera A; Mayani H
Leuk Res; 2005 Feb; 29(2):215-24. PubMed ID: 15607371
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury.
Lu Z; Chang W; Meng S; Xu X; Xie J; Guo F; Yang Y; Qiu H; Liu L
Stem Cell Res Ther; 2019 Dec; 10(1):372. PubMed ID: 31801626
[TBL] [Abstract][Full Text] [Related]
12. Adaptive Regulation of Osteopontin Production by Dendritic Cells Through the Bidirectional Interaction With Mesenchymal Stromal Cells.
Scutera S; Salvi V; Lorenzi L; Piersigilli G; Lonardi S; Alotto D; Casarin S; Castagnoli C; Dander E; D'Amico G; Sozzani S; Musso T
Front Immunol; 2018; 9():1207. PubMed ID: 29910810
[TBL] [Abstract][Full Text] [Related]
13. Impaired generation of bone marrow CD34-derived dendritic cells with low peripheral blood subsets in patients with myelodysplastic syndrome.
Micheva I; Thanopoulou E; Michalopoulou S; Kakagianni T; Kouraklis-Symeonidis A; Symeonidis A; Zoumbos N
Br J Haematol; 2004 Sep; 126(6):806-14. PubMed ID: 15352984
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation.
Aldinucci A; Rizzetto L; Pieri L; Nosi D; Romagnoli P; Biagioli T; Mazzanti B; Saccardi R; Beltrame L; Massacesi L; Cavalieri D; Ballerini C
J Immunol; 2010 Nov; 185(9):5102-10. PubMed ID: 20889545
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
16. Effect of mesenchymal stem cell-derived exosomes on the induction of mouse tolerogenic dendritic cells.
Shahir M; Mahmoud Hashemi S; Asadirad A; Varahram M; Kazempour-Dizaji M; Folkerts G; Garssen J; Adcock I; Mortaz E
J Cell Physiol; 2020 Oct; 235(10):7043-7055. PubMed ID: 32043593
[TBL] [Abstract][Full Text] [Related]
17. Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway.
Liu WH; Liu JJ; Wu J; Zhang LL; Liu F; Yin L; Zhang MM; Yu B
PLoS One; 2013; 8(1):e55487. PubMed ID: 23383203
[TBL] [Abstract][Full Text] [Related]
18. TGF-β favors bone marrow-derived dendritic cells to acquire tolerogenic properties.
Song SS; Yuan PF; Chen JY; Fu JJ; Wu HX; Lu JT; Wei W
Immunol Invest; 2014; 43(4):360-9. PubMed ID: 24484319
[TBL] [Abstract][Full Text] [Related]
19. Leukaemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with myelodysplasia: a methodological approach under serum-free culture conditions.
Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schmid C; Schweiger C; Kolb HJ; Schmetzer HM
Scand J Immunol; 2005 Jul; 62(1):75-85. PubMed ID: 16091127
[TBL] [Abstract][Full Text] [Related]
20. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells.
Jiang XX; Zhang Y; Liu B; Zhang SX; Wu Y; Yu XD; Mao N
Blood; 2005 May; 105(10):4120-6. PubMed ID: 15692068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
